Hearing loss in children treated for multidrug-resistant tuberculosis
Authors:
- James A. SeddonJSJames A. Seddon
- Stephanie TheeSTStephanie Thee
- Kayleen JacobsKJKayleen Jacobs
- Adam EbrahimAEAdam Ebrahim
- Anneke C. HesselingAHAnneke C. Hesseling
- H. Simon SchaafHSH. Simon Schaaf
- 1 April 2013
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 66 (4) , 320-329
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Culture-Confirmed Multidrug-Resistant Tuberculosis in Children: Clinical Features, Treatment, and OutcomeClinical Infectious Diseases, 2011
- Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive studyThe Lancet Infectious Diseases, 2011
- Aminoglycoside induced ototoxicityToxicology, 2008
- Aminoglycoside-Induced OtotoxicityCurrent Pharmaceutical Design, 2007
- Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2006
- Community-Based Therapy for Children With Multidrug-Resistant TuberculosisPediatrics, 2006
- Childhood tuberculosis in an urban population in South Africa: burden and risk factorArchives of Disease in Childhood, 1999
- Aminoglycosides: NephrotoxicityAntimicrobial Agents and Chemotherapy, 1999
- Arninoglycoside toxicity in infants and childrenThe American Journal of Medicine, 1986